Changes in KL‐6 levels were significantly inversely correlated with changes in percentages of FEV1, TLC, diffusing capacity of the lung for carbon monoxide (DLCO), and residual volume in polymyositis/dermatomyositis patients with ILD.19, 20. This evidence concerns the gene MUC1 and polymyositis.